REPCF - RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc., formerly Newcastle Resources Ltd., through its subsidiary, TrichoScience Innovations Inc. (TrichoScience), is engaged in the business of developing a hair cell replication technology, that is intended to permanently, and non-surgically, cure baldness and hair loss in men and women. The Company�s cellular replication and implantation technology is designed to grow new hair follicles in patients suffering from androgenetic alopecia, as well as other causes of balding or thinning scalp hair. On December 22, 2010, the Company completed 55.3% acquisition of TrichoScience. On December 22, 2010, the Company completed the acquisition of 583885 B.C. Ltd. (583885). On December 22, 2010, it sold its interest in and to the Lennie Property.